Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Public Policy

  • News

    Market Watch

    August 2, 2010

    New Drugs, Indications, Dosage Forms, and Approvals Hydromorphone extended-release tablets (Exalgo) have been approved by the FDA as a once-daily treatment for managing moderate to severe pain in opioid-tolerant patients needing continuous opioid analgesia for an extended period of time.1 This f

  • News

    Raise the ‘Red Flags’

    August 2, 2010

    Congressional inaction puts medical practices at risk

  • 1
    News

    Radical vs. Sensible

    August 2, 2010

    Healthcare improvement ideas for CMS’ new director

  • 1
    Opinion

    Financial Risk

    August 2, 2010

    Hospitalists should press for a permanent payment-formula fix

  • News

    Observation Care

    July 1, 2010

    Detailed notes, correct codes critical to charge capture

  • 1
    News

    Rule Proposes Electronic Prescription of Controlled Substances, Doesn’t Scrap Pen-and-Paper Method

    July 1, 2010

    Is it true that the Drug Enforcement Administration (DEA) is going to allow doctors to prescribe controlled drugs electronically?

  • 1
    News

    Focused Practice in Hospital Medicine Worth the Additional Cost

    June 1, 2010

    Focused Practice in Hospital Medicine Worth the Additional Cost Why are we being required to fork over an extra $380 for the Focused Practice in Hospital Medicine MOC? This feels like the icing on the cake of already a major ripoff. Dr. Ragan Grass Valley, Calif. Dr.

  • 1
    Opinion

    Square Peg, Square Hole

    June 1, 2010

    Ensure your hospitalists are recognized, valued members of medical staff

  • News

    Variable Rate

    June 1, 2010

    Disciplinary action against doctors differs greatly from state to state

  • 1
    News

    The Cost of Regulation

    June 1, 2010

    Resident restrictions burden teaching hospitals, provide hospitalists new opportunities

Previous1 … 79 80 81 82 83 … 116Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences